![]() LabConnect LabConnect is a provider of central laboratory support services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare and orphan diseases. | ![]() Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. | ![]() Avacta Group Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics | ![]() Kura Oncology Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers. | ||
Founding Date | Founding Date 2002 | Founding Date 1995 | Founding Date 1994 | Founding Date 2003 | Founding Date 2007 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Johnson City, US HQ Buenos Aires, AR Sydney, AU Minsk, BY Tbilisi, GE Mumbai, IN Tel Aviv Yafo, IL see more | Locations Austin, US HQ Calabasas, US Englewood, US | Locations Newark, US HQ | Locations Wetherby, GB HQ London, GB Whittlesford, GB | Locations San Diego, US HQ Boston, US San Diego, US San Diego, US |
Employees | Employees 1961% decrease | Employees 1131% increase | Employees 781% decrease | Employees 154 | Employees 5712% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 264.5 m | Valuation ($) 1.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £24.4m (FY, 2024) | Revenue (est.) $67.5m (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 24.5m (almost 9 years ago) | Latest funding round N/A | Latest funding round $ 10m (almost 16 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 28.5m | Total funding raised N/A | Total funding raised $ 37m | Total funding raised N/A | Total funding raised N/A |
Esoterix is a company that specializes in endocrinology and coagulation testing services.
View company
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View company
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics
View company
Kura Oncology is a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
View company